Uniquity Bio Welcomes Matthew Hartzell as Chief Financial Officer

MALVERN, Pa.--(BUSINESS WIRE)--Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation and backed by Blackstone Life Sciences, today announced the appointment of Matthew Hartzell as Chief Financial Officer. Mr. Hartzell most recently served as a Vice President in the Global Healthcare Group at Goldman Sachs, where he focused on the biotech industry. He brings nearly a decade of experience partnering with executive teams and boards of innovative growth comp